Maladaptive inflammation is a major suspect in progressive neurodegeneration, but the underlying mechanisms are difficult to envisage in part because reactive glial cells at lesion sites secrete both proinflammatory and anti-inflammatory mediators. We now report that astrocytes modulate neuronal resilience to inflammatory insults through the phosphatase calcineurin. In quiescent astrocytes, inflammatory mediators such as tumor necrosis factor-␣ (TNF-␣) recruits calcineurin to stimulate a canonical inflammatory pathway involving the transcription factors nuclear factor B (NFB) and nuclear factor of activated T-cells (NFAT). However, in reactive astrocytes, local anti-inflammatory mediators such as insulin-like growth factor I also recruit calcineurin but, in this case, to inhibit NFB/NFAT. Proof of concept experiments in vitro showed that expression of constitutively active calcineurin in astrocytes abrogated the inflammatory response after TNF-␣ or endotoxins and markedly enhanced neuronal survival. Furthermore, regulated expression of constitutively active calcineurin in astrocytes markedly reduced inflammatory injury in transgenic mice, in a calcineurin-dependent manner. These results suggest that calcineurin forms part of a molecular pathway whereby reactive astrocytes determine the outcome of the neuroinflammatory process by directing it toward either its resolution or its progression.
Introduction
Inflammation, a common denominator among the diverse list of neurodegenerative diseases, has been implicated recently as a key mechanism responsible for the progressive nature of neurodegeneration (Minghetti, 2005) . As a result of a low turnover rate and little ability to recover from injury, neurons are extremely vulnerable to self-destructive inflammatory processes. This might hinder the recovery of neurological function at sites of inflammation or even exacerbate neuronal injury through a pathological cascade. The hallmark of brain inflammation is the activation of glial cells (Ridet et al., 1997) . These cells constitute essential partners of neurons, providing functional support through a myriad of intercellular links (Seifert et al., 2006) . However, during inflammation, glial cells may play a double-edged role because, depending on the course of the inflammatory process, glial-derived factors may result in being either beneficial or detrimental to neurons (Wyss-Coray and Mucke, 2002) . Therefore, a balance between proinflammatory and anti-inflammatory signaling arising from a diversity of cells within the affected brain area will eventually determine the outcome of the inflammatory process. If the proinflammatory cascade, mounted mostly by activated microglia and astrocytes, is harnessed, the neuroprotective signals that these two types of glial cells produce, together with those produced by endothelial cells and neurons, will tilt the balance toward resolution of the process. Although the proinflammatory function of astroglia is usually considered not to be as prominent as that of microglia (Streit et al., 1999) , astroglia become activated in response to immunologic challenges or brain injuries (Seifert et al., 2006) . In fact, reactive astrogliosis is a marker of brain damage in general (Ridet et al., 1997) . At the same time, activated astrocytes provide support for damaged neural tissues through several mechanisms, including release of neurotrophic factors and downregulation of proinflammatory messengers (Wyss-Coray and Mucke, 2002) . However, the cellular and molecular pathways underlying interactions between proinflammatory and anti-inflammatory signaling within brain tissue are not well delineated.
While analyzing the anti-inflammatory actions of insulin-like growth factor I (IGF-I), a potent neuroprotective signal upregulated in all types of brain lesions (Torres-Aleman, 2000) , we observed that inhibition of IGF-I expression at inflammatory sites exacerbated astroglial reactivity (Fernandez et al., 1997) . This effect was probably related to the antagonistic actions of IGF-I on tumor necrosis factor-␣ (TNF-␣) signaling onto astrocytes, an effect in which the phosphatase calcineurin appears to be involved (Pons and Torres-Aleman, 2000) . In turn, TNF-␣ participates in glial-mediated inflammation through activation of the canonical nuclear factor B (NFB) pathway (Ginis et al., 2002) . to brain injury. Two days later, Dox treatment was discontinued in a subset of animals, and the effect of delayed ⌬CnA expression was determined 5 d after injury. Another group of animals treated for 1 week with ϮDox received an LPS injection (Escherichia coli serotype 055:B5; 0.5 g/2 l sterile pyrogen-free saline; Sigma) in the parietal cortex over 2 min with a Hamilton syringe at the following coordinates: 1.3 mm anteroposterior, 1.5 mm lateral, and 1 mm dorsoventral. Animals were allowed to survive for 1, 3, and 10 d. A second group of AIC mice also treated for 1 week before inflammatory challenge with or without Dox received a single intraperitoneal injection of LPS (1 mg/kg, in 100 l vehicle) or vehicle solution. Animals were allowed to survive for 1 and 5 d. To determine perilesion changes, inflammatory markers and neuronal death were determined by Western blot (WB) and immunofluorescence. For biochemical studies, a block of brain parenchyma surrounding the stab wound or injection site (2 mm wide, 4 mm high) was dissected from each animal. Ten animals per group were used.
In vitro experiments. Pure astroglial cultures [Ͼ95% GFAP-positive (GFAP ϩ ), OX-42-negative (OX-42 Ϫ ), A2B5
Ϫ cells] were prepared as described previously (Pons and Torres-Aleman, 2000) . Briefly, postnatal (day 3-4) brains were dissected and immersed in ice-cold DMEM/F-12; Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS). Cortex and hippocampus were removed and cut into 1 mm pieces. Tissue fragments were dissociated mechanically, and the resulting cell suspension was centrifuged (1000 rpm/10 min) and plated in DMEM/ F-12 with 10% FBS, 5 ϫ 10 5 cells per well. Cerebellar granule cells from 7-d-old rats were grown in plates covered with poly-L-lysine and Neurobasal plus B27 (Invitrogen), glutamine, and 25 mM KCl. Under these conditions, ϳ95% of the cells are neurons (␤3-tubulin ϩ ). Neurons were plated at 1 ϫ 10 6 cells per well. Astrocyte-neuron cocultures were prepared as follows: astrocytes were plated, and, when they were 70% confluent, the medium was removed and neurons were plated onto them with freshly added medium. Cultures were allowed to grow for 4 d. In time course experiments with transfected neuronal cultures or neuronastrocyte cocultures, cells were treated with cytotoxic doses of LPS (E. coli serotype 0127:B8; 1 g/ml; Sigma) or TNF-␣ (20 ng/ml) for up to 72 and 24 h, respectively. The schedule of the experiments in transfected cocultures is detailed in Figure 1 B. The calcineurin inhibitor CsA (500 nM) was added to transfected astrocytes 24 h before plating the neurons to avoid inhibition of neuronal calcineurin (see Fig. 1 B) . The proteasome inhibitor MG-132 (1 M) was added 1 h before LPS or TNF-␣ stimulation of cocultures (see Fig. 1 B) . Cultured cells were transfected using Fugene reagent (Roche, Basel, Switzerland) when 70% confluent. Plasmids transfected were as follows: pGFAP-tTA (GFAP) and TetO-⌬CnA (⌬CnA); pNFB-secreted alkaline phosphatase (SEAP) or pNFAT-SEAP and pCMV-⌬CnA. Mock transfection was done with pCMV vector.
In experiments using wild-type (wt) cultures, cells were exposed for 16 h to LPS or for 3 h to TNF-␣ before adding IGF-I (100 nM), and cell death was assessed 2 h later. When investigating the role of calcineurin in IGF-I neuroprotection in wt cells, CsA was added 1 h before IGF-I. In experiments using cells obtained from AIC mice, doxycycline (10 g/ml) was added to the cultures at the same time that astrocytes were plated to inhibit ⌬CnA expression from the onset of the experiment.
In vitro assays. Production of reactive oxygen species (ROS) was determined by analyzing H 2 O 2 levels in the cultures as described previously (Brera et al., 2000) , with minor modifications. Briefly, the method uses the nonfluorescent cell-permeant compound 2Ј,7Ј-dichlorofluorescein diacetate (Invitrogen) which can be oxidized by peroxides producing the fluorescent compound 2Ј,7Ј-dichlorofluorescein. Generation of peroxides was measured in a FLUOstar plate reader (BMG Lab technologies, Offenburg, Germany) at an excitation wavelength of 485 nm and an emission of 520 nm.
To measure the activity of the transcription factors NFB and NFAT, we used the SEAP reporter system that determines the levels of enzymatically active SEAP. Assays were performed according to the protocol of the manufacturer (Clontech). Transient transfections were performed with 250 ng of the plasmids pNFB-SEAP and pNFAT-SEAP, and, after 24 h, luminescence was quantified using a Sirius Luminometer (Berthold Detection Systems, Pforzheim, Germany).
Calcineurin activity was determined using a calcineurin activity kit (Calbiochem). Culture cells and mouse brain tissue were homogenized in lysis buffer (50 mM Tris, 1 mM DTT, 100 M EDTA, 100 M EGTA, and 0.2% NP-40, pH 7.5) and protease inhibitor cocktail (Roche). To remove free phosphate, supernatant extracts were added to a desalting column resin. Phosphatase assays were performed in a total of 100 l in assay buffer (200 mM NaCl, 100 mM Tris, 12 mM MgCl 2 , 1 mM CaCl 2 , 1 mM DTT, and 0.05% NP-40, pH 7.5). Recombinant human calcineurin at 50 U/l, 25 M calmodulin, and 10 l RII phosphopeptide were used per assay. When indicated, EGTA was added (20 mM), and assays were incubated at 30°C for 30 min. Calcineurin phosphatase activity was measured by luminescent detection at 620 nm of free phosphate released from the calcineurinspecific RII phosphopeptide using the green reagent. Assays were performed in duplicate at each time point in three separate experiments.
Reverse transcription-PCR was performed using the QuantumRNA Universal 18S system from Ambion (Austin, TX). Total RNA was isolated from cultured cells or mouse tissues using Trizol (Invitrogen). Equivalent amounts of total RNA served as template for cDNA synthesis using M-MLV (Moloney murine leukemia virus) reverse transcriptase (Promega) at 42°C, followed by PCR using specific primers directed to the 3Ј end of the GFAP promoter and the 5Ј end of ⌬CnA: forward, 5Ј GATGTGCTTTAC-TAAGTCATC 3Ј; and reverse, 5Ј CAGT-TCATCGTCGGAGCAGA 3Ј. RNA 18S was quantitated as a loading control.
For RNA interference experiments [Silencer small interference RNA (siRNA) transfection II kit; Ambion], three different double-stranded CnA siRNAs (with sequences CnA1, 5Ј GGAA-GUGUUUGAUAACGAU 3Ј; CnA2, 5Ј GGAAG-GCAGGCUGGAAGAA 3Ј; CnA3, 5Ј GGAUU-CUCACCACAACAU 3Ј) were transfected (30 nM) with siPORT NeoFX (Ambion) into primary astrocytes (12-well plates containing 9 ϫ 10 4 cells/ml). Seventy-two hours later, cultures were Only ⌬CnA-transfected astrocytes produced the truncated mutant form of calcineurin (⌬CnA; blots). Levels of endogenous calcineurin remained unaffected. B, Schedule followed for coculture of astrocytes and neurons. Astrocytes were plated and transfected with corresponding DNAs, and neurons were added 24 h later. Thereafter, cocultures were challenged with inflammatory stimuli (LPS 4 or TNF-␣) for various times before analysis of neuronal death after a total of 4 d in coculture. Inhibitors such as CsA or MG-132 were added at indicated times. C, Photomicrographs, Representative double immunocytochemical staining used to identify apoptotic (activated caspase 3 ϩ cells; red) neurons (␤3-tubulin ϩ cells; green) after inflammatory challenge. Histograms, Neurons cocultured with mock-transfected astrocytes (CMV; striped left histograms) die soon after LPS (top histograms) or TNF-␣ addition (bottom histograms), whereas when cocultured with astrocytes expressing ⌬CnA (black right histograms), they show a significantly greater resistance to these inflammatory stimuli (**p Ͻ 0.01 vs respective CMV times). Number of living neurons are expressed as percentage of unstimulated control cultures at time 0. Scale bar, 100 m. D, The release of ROS in response to proinflammatory stimuli (LPS or TNF-␣) was fully abrogated when astrocytes (but not neurons) expressed ⌬CnA but not the empty vector (CMV). Note that, with the doses of LPS or TNF-␣ used, astrocytes did not produce ROS. All experiments were repeated six times. ***p Ͻ 0.001. stimulated with LPS (1 g/ml) overnight. Cells were lysed, and levels of CnA, iNOS2, Cox2, GAPDH (as a siRNA internal control), and ␤-actin were determined by WB. A nontargeting siRNA and a GAPDH siRNA were used as negative and positive controls, respectively. Assays were performed in triplicate.
Immunofluorescence. Immunocytochemistry was performed as described previously (Trejo et al., 2001) . Animals (n ϭ 10 per group) were deeply anesthetized with pentobarbital (50 mg/kg) and perfused transcardially with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 (PB). Coronal 40-m-thick sections were cut in a vibratome and collected in PBS. For in vitro experiments, cells were plated on 20 mm coverslips and fixed. Coverslips or free-floating brain sections were blocked with 5% normal horse serum and incubated overnight at 4°C with the respective primary antibody in PB containing 0.1% bovine albumin, 3% horse serum, and 0.2% Triton X-100. After several washes in PB, sections were incubated with an Alexa-coupled secondary antibody (1:1000). Omission of primary antibody was used as control. Neuronal death was determined by a single investigator in uncoded brain sections and cultures, as described (Fernandez et al., 1998) . ␤3-Tubulin ϩ /activated caspase 3 ϩ double-stained cells were scored and expressed as percentage of total ␤3-tubulin ϩ cells. Activated caspase 3 ϩ neurons were scored in six consecutive sections in a 1 mm 2 area or in six different microscope fields for each coverslip when counting cell cultures. MH-CII ϩ and CD11b ϩ cells in double-stained brain sections from lesioned areas were scored and expressed as number of cells per square millimeter. Confocal analysis was performed in a Leica (Bensheim, Germany) microscope.
Immunoassays. Animals were perfused transcardially with saline before collection of brain samples for biochemical analysis. Cells or cerebral cortex pieces (1 mm around lesion or injection) were homogenized in ice-cold buffer consisting of 20 mM Tris HCl, 150 mM NaCl, 5 mM EDTA, 10% glycerol, 1% NP-40, 400 M sodium orthovanadate, and protease inhibitors (200 mM PMSF, 1 g/ml aprotinin, and 1 g/ml leupeptin). WB and immunoprecipitation were performed as described previously (Pons and Torres-Aleman, 2000) . WB membranes were reblotted with either the same antibody used for immunoprecipitation or with ␤-actin as internal standards and to normalize for protein load. Levels of the protein under study were expressed relative to protein load in each lane. Densitometric analysis was performed using Quantity One software (Bio-Rad). IGF-I was quantified in cell lysates and media by sandwich ELISA using mouse IGF-I as a standard (IBT, Reutlingen, Germany). Briefly, 96-well plates were covered with a monoclonal anti-mouse IGF-I antibody (1:1000; R & D Systems, Minneapolis, MN) at 4°C overnight. After several washes with PBS, pH 7.4, wells were incubated with a blocking solution containing PBS, pH 7.4, 5% Tween 20, 5% sucrose, and 0.05% sodium azide, 2 h at room temperature. After three washes with PBS, pH 7.4, plates were placed at 4°C overnight. Samples were added and maintained at 4°C overnight. After washes, plates were incubated with a biotinylated anti-mouse IGF-I antibody (1:1000; R & D Systems) at 4°C overnight. After washes, plates were incubated with a streptavidin horseradish peroxidase conjugate (1:20,000; GE Healthcare, Little Chalfont, UK). After washing, o-phenyllenediamine dihydrochloride (Sigma) was added during 30 min at room temperature. Absorbance was measured in a spectrophotometer at 450 nm.
A protein array (1.1; Raybiotech, Norcross, GA) to quantitate relative expression of 40 different inflammation-related factors was used following the instructions of the manufacturer. Membranes were blocked for 30 min and incubated with 50 g of AIC astrocyte culture lysate or with 500 g of AIC tissue homogenate for 2 h at room temperature and then washed for 30 min and incubated with a biotin-conjugated antibody (1:250) for 2 h. After consecutive washes, streptavidin-conjugated peroxidase (1:1000) was added for 1 h at room temperature. Membranes were washed thoroughly and exposed to ECL substrate (GE Healthcare), followed by apposition of the membranes with autoradiographic film (GE Healthcare) for 1 min. The film was scanned, and spots were digitized into pixel densities using the Quantity One imaging software (BioRad). The ratio of relative expression was established after subtraction of the background intensity and comparison with the positive spots available in the membrane. and TetO-⌬CnA (⌬CnA) in cultured wt astrocytes allows Dox-regulated activation of calcineurin. Both control (wt) and GFAP-tTA-transduced astrocytes show lower and Doxindependent calcineurin activity. ***p Ͻ 0.001. B, Astrocyte inducible calcineurin (AIC mouse 5) but not single mutant TetO-⌬CnA or GFAP-tTA mice produced ⌬CnA protein, a truncated form of the wt protein. Wild-type calcineurin (CnA) was detected in the three animals. C, Calcineurin activity in brain extracts from AIC mice (lines 5, 7) was markedly elevated compared with a wt control and was regulated by Dox . ***p Ͻ 0.001. D, Expression of ⌬CnA mRNA in the brain of AIC mice was found postnatally and maintained thereafter. E, ⌬CnA mRNA levels in the brain of AIC mice were inhibited within hours after addition of Dox to the drinking water. F, Expression of ⌬CnA protein in astrocytes obtained from AIC mice was regulated by Dox in the culture medium. Controls are astrocytes from wt mice. G, Astrocytes from AIC mice secrete Cu/Zn SOD (SOD) to the medium after LPS challenge in a calcineurin-dependent manner. In the presence of Dox in the culture medium (which suppresses ⌬CnA expression), levels of SOD remain unaffected. Note that expression of ⌬CnA is sufficient to increase SOD levels. Representative blot is shown (n ϭ 6). H, AIC astrocytes also secrete greater amounts of IGF-I after LPS in the absence of Dox in the culture medium (*p Ͻ 0.05 vs control and **p Ͻ 0.01 vs ϩDox and vs control; n ϭ 6).
Statistics. Statistical analyses were performed with a t test when comparing two groups and a two-way ANOVA for comparing multiple groups. Statistical significance was established when p Ͻ 0.05. Results shown are mean Ϯ SEM.
Results
Calcineurin participates in astrocytemediated neuroprotection against inflammatory damage As mentioned above, we previously found that the phosphatase calcineurin mediates the anti-inflammatory effects of IGF-I on astrocytes (Pons and Torres-Aleman, 2000) . To gain additional insight into the biological significance of this antiinflammatory activity, we transfected wt rat astrocytes with a constitutively active form of the catalytic subunit of calcineurin (⌬CnA). Transfected astrocytes showed high levels of ⌬CnA together with marked increases in calcineurin activity (Fig. 1 A) . Next, we tested the neuroprotective activity of ⌬CnA-transfected astrocytes against inflammatory damage. When rat cerebellar neurons were cocultured with mocktransfected astrocytes [cytomegalovirus (CMV)-transfected astrocytes] and submitted to TNF-␣ or LPS challenge, they died within 24 -72 h, respectively (Fig. 1C,  left histograms) . However, when neurons were cocultured with astrocytes expressing ⌬CnA, neuronal death after either LPS (1 g/ml) or TNF-␣ (20 ng/ml) was markedly abrogated (Fig. 1C, right histograms) ( p Ͻ 0.01 vs CMV-transfected astrocytes). Neuroprotection was mediated at least in part by humoral factors because conditioned medium from ⌬CnA-expressing surrounding the lesion site. Scale bar, 100 m. C, Levels of both Cox2 and iNOS2 at the injury site were also dramatically reduced in ⌬CnA-expressing AIC mice ( p Ͻ 0.001 vs AIC ϩDox, for both markers; n ϭ 10 at 5 d after lesion). Control, Sham operated; Inj, brain injury. D, Levels of MHCII (a marker of microglia activation) were increased at the lesion site 5 d after brain trauma in AIC mice not expressing ⌬CnA (ϩDox; n ϭ 10), but the increase was smaller when expressing ⌬CnA (ϪDox; n ϭ 10). Protein load in gels was normalized by measuring ␤-actin levels. Bottom histograms, Number of MH-CII ϩ , CD11b ϩ (a marker of infiltrating macrophages), and double MHCII ϩ -CD11b ϩ cells at the lesioned site in AIC mice treated with Dox 1 week before lesion (ϩDox), not treated with Dox (ϪDox), or treated with Dox until 2 d after the lesion (ϮDox). In the absence of Dox, when ⌬CnA is expressed in astrocytes, the number of MHCII ϩ and MHCII ϩ -CD11b ϩ cells is significantly reduced, whereas CD11b ϩ cells remain unaffected. Note that the reduction is also present when AIC mice started to express ⌬CnA 2 d after the lesion was produced (***p Ͻ 0.001 vs ϪDox and ϮDox; n ϭ 5 per group). Photomicrographs, Representative MHCII ϩ and CDb11 ϩ cells located in the vicinity of the lesion site (asterisk). Cell counts were done in double-stained brain sections. Scale bar, 50 m.
astrocytes protected neurons against inflammatory damage after 16 h of exposure to LPS (36 Ϯ 4% of neurons alive in conditioned medium from ⌬CnA astrocytes vs 1 Ϯ 1.2% neurons alive in conditioned medium from CMV astrocytes; p Ͻ 0.05) or 3 h after TNF-␣ (data not shown). This protective action was not observed when neurons themselves expressed ⌬CnA (supplemental Fig. 1 A, available at www.jneurosci.org as supplemental material). At the doses used, LPS or TNF-␣ did not affect astrocyte survival (data not shown). In addition, when calcineurin activity was inhibited in ⌬CnA-expressing astrocytes by adding the calcineurin inhibitor CsA 24 h before coculturing them with neurons, neuroprotection against LPS or TNF-␣ (data not shown) was significantly diminished (72 Ϯ 5% of neurons alive compared with 35 Ϯ 5% alive when CsA was added; p Ͻ 0.05). Furthermore, neuronal production of ROS in response to LPS or TNF-␣ challenge was completely abrogated when neurons were cocultured with ⌬CnA-expressing astrocytes but not when neurons were cultured alone or with mock-transfected astrocytes ( p Ͻ 0.001 vs CMV transfected) (Fig. 1 D) .
Astrocyte calcineurin protects against brain inflammatory injury
We next designed in vivo"proof-of-concept" experiments to establish an anti-inflammatory action of calcineurin in astrocytes. Double transgenic mice with Dox-regulated expression of ⌬CnA in astrocytes were generated by crossbreeding mice expressing a murine GFAP promoter-driven tTA transgene with mice expressing a TetO-driven ⌬CnA transgene. We first corroborated that in vitro expression of these transgenes allowed Doxregulated calcineurin activity in wt astrocytes cotransfected with them (Fig. 2 A) . In vivo, double transgenic AIC mice expressed ⌬CnA in the brain (Fig. 2 B) and markedly enhanced calcineurin activity in a Dox-regulated manner (Fig. 2C) . Detailed characterization of AIC mice confirmed the expression of the two transgenes (GFAP-tTA and TetO-⌬CnA) (supplemental Fig. 1 B, available at www.jneurosci.org as supplemental material), expression of ⌬CnA mRNA in the brain (supplemental Fig. 1C , available at www.jneurosci.org as supplemental material), and Dox-regulated calcineurin immunoreactivity in astrocytes (supplemental Fig. 1 D, available at www.jneurosci.org as supplemental material). Expression of ⌬CnA mRNA in AIC brain appeared early after birth and was maintained thereafter (Fig. 2 D) .
Importantly, when AIC mice received Dox in the drinking water, ⌬CnA mRNA was inhibited within 24 -48 h (Fig. 2 E) . Because expression of ⌬CnA in cultured AIC astrocytes was also inhibited by adding Dox (10 g/ml) at the onset of the culture (Fig. 2 F) , we concluded that calcineurin activity in AIC astrocytes was regulated by Dox in vivo and in vitro. That calcineurin activity is regulated by Dox was indirectly confirmed by the observation that Dox regulated the release by AIC astrocytes of humoral neuroprotective signals such as Cu/Zn SOD or IGF-I that are known to be functionally associated with calcineurin (Tokheim and Martin, 2006; Alfieri et al., 2007) . Thus, in response to proinflammatory challenge with LPS, AIC astrocytes secreted larger amounts of SOD and IGF-I when cultured without Dox (Fig.  2G,H ) . Similar results were obtained in wild-type rat astrocytes transduced with ⌬CnA and challenged with LPS (supplemental Fig. 1 E, available at www.jneurosci.org as supplemental material) or TNF-␣ (data not shown), respectively. When the IGF-I receptor antagonist PPP (120 nM) was added to LPS-stimulated cocultures containing ⌬CnA-expressing astrocytes, the neuroprotective action of astrocytes was moderately reduced: ϳ70% of the neurons were alive in ⌬CnA-expressing astrocyte cocultures, whereas after adding PPP, ϳ60% of neurons were alive. However, in cocultures with mock-transfected astrocytes, the presence of PPP reduced to 50% the neuronal survival induced by astrocytes after LPS insult (from ϳ30 to ϳ15% neurons alive).
Once we observed that calcineurin protects neurons against inflammatory death in vitro, we explored whether calcineurin in AIC astrocytes protected neurons against brain inflammation in vivo. AIC mice submitted to a penetrating brain injury that produces an inflammatory response in the lesioned area were analyzed 5, 10, 20, 30, and 60 d later. At 60 d, weak glial reactivity was still present in AIC mice not expressing ⌬CnA, but the rest of the changes analyzed were resolved within 1 month. Because all pathological changes examined peaked within 5-10 d of the lesion, we analyzed them in detail 5 d after the lesion. In AIC mice with suppressed ⌬CnA expression by treatment with Dox (ϩDox AIC mice), neuronal death (identified as double-stained ␤3-tubulin ϩ -activated caspase 3 ϩ cells) 5 d after brain injury was prominent (Fig. 3A) . Dox-treated AIC mice also showed reactive astroglial cells (GFAP ϩ cells) in the lesion site. These reactive astrocytes abundantly expressed proinflammatory markers such as Cox2 (Fig. 3 B, C) and iNOS2 (Fig. 3C) . In addition, Doxtreated AIC mice show detectable levels of the reactive microglia marker MHCII, as well as the presence of MHCII ϩ and CD11b ϩ cells in the lesioned area (Fig. 3D) . Notably, MHCII levels, as well as MHCII ϩ and double-stained MHCII ϩ /CD11b ϩ cells, but not CD11b ϩ cells that remained elevated, were significantly attenuated in AIC mice expressing ⌬CnA before injury ( p Ͻ 0.001 vs ϩDox AIC mice; n ϭ 10) (Fig. 3D , ϪDox) (supplemental Fig.  2 A, available at www.jneurosci.org as supplemental material). At 5 d after lesion, the number of apoptotic neurons in the lesioned area was significantly decreased when ⌬CnA was expressed: 20.6 Ϯ 1.0 ␤3-tubulin ϩ -activated caspase 3 ϩ cells/mm 2 in ϪDox vs 82.6 Ϯ 1.7 cells/mm 2 in ϩDox AIC mice ( p Ͻ 0.001; n ϭ 10). Screening of proinflammatory protein levels with a protein array at day 5 after lesion (Raybiotech) (supplemental Results, available at www.jneurosci.org as supplemental material) confirmed a general downregulation by ⌬CnA expression (Table 1) . Microglia reactivity and macrophage infiltration at the damaged site, determined by levels of MHCII and number of MHCII ϩ and CD11b ϩ cells, was also attenuated (Fig. 3D) . Furthermore, as seen in vitro, the number and the intensity of staining of IGF-Iimmunoreactive astrocytes (IGF-I ϩ /GFAP ϩ cells) in the vicinity of the lesion was greater in AIC mice expressing ⌬CnA (from 83 Ϯ 16 astrocytes/mm 2 in ϩDox to 102 Ϯ 27 astrocytes/mm 2 in ϪDox; p Ͻ 0.05). Notably, when expression of ⌬CnA was allowed in astrocytes after brain trauma, once the inflammatory cascade is active, neuronal death was still markedly attenuated. Thus, in AIC mice in which Dox treatment was discontinued 2 d after injury (ϮDox mice) to allow ⌬CnA expression (that starts within 24 h of Dox withdrawal), the number of apoptotic neurons 5 d after injury was markedly reduced, close to the reduction seen when ⌬CnA expression was allowed before injury (ϪDox mice). There were 32 Ϯ 0.7 apoptotic neurons/mm 2 in ϮDox, 17 Ϯ 2.2 neurons in ϪDox, but 75 Ϯ 5.3 neurons in ϩDox AIC mice ( p Ͻ 0.001 vs ϮDox and ϪDox groups; n ϭ 5 per group). In ϮDox AIC mice, microglia reactivity was also significantly reduced (Fig. 3D , bottom histograms) ( p Ͻ 0.001 vs ϩDox group).
Injection of bacterial endotoxins (LPS) into the brain is a well established model of inflammatory processes associated with human neurotropic infections (Fassbender et al., 2004; Felts et al., 2005) . After brain LPS injection to AIC mice, pathological alterations peaked within 1-3 d and were resolved 10 d later. We examined the response to ⌬CnA expression 3 d after LPS challenge and found an attenuated inflammatory response when ⌬CnA was expressed. Significantly reduced neuronal death after LPS injection was seen in AIC mice without Dox before endotoxic challenge: 12.0 Ϯ 1.8 ␤3-tubulin ϩ /activated caspase 3 ϩ cells/mm 2 in ϪDox vs 63.3 Ϯ 1.0 ␤3-tubulin ϩ /activated caspase 3 ϩ cells/mm 2 in ϩDox AIC mice ( p Ͻ 0.001; n ϭ 10). As seen after brain trauma, markers of glial reactivity were also reduced in ⌬CnA-expressing AIC mice. These included reduced activation of astrocytes (GFAP ϩ /iNOS2 ϩ ) (Fig. 4 A) , decreased levels of proinflammatory mediators in the lesioned area ( p Ͻ 0.001 vs AIC ϩDox; n ϭ 10) (Fig. 4 B, Table 1 ) (supplemental Fig. 2 B, available at www.jneurosci.org as supplemental material), and reduced microglia activation (data not shown). Furthermore, systemic administration of LPS to mimic central inflammatory responses to infection, a common complication in elderly demented patients (Perry et al., 2003) , resulted also in an attenuated brain inflammatory response when AIC mice expressed ⌬CnA. Five days after intraperitoneal injection of LPS, the levels of Cox2 and iNOS2 in cortical tissue of AIC (ϪDox) mice were reduced compared with AIC mice receiving Dox in the drinking water (Fig. 4C) (supplemental Fig. 2C , available at www.jneurosci.org as supplemental material) ( p Ͻ 0.001 vs AIC ϩDox; n ϭ 10).
Calcineurin inhibits a canonical proinflammatory pathway in astrocytes
We then explored mechanisms underlying reduced inflammatory responses when calcineurin is activated in astrocytes before inflammatory challenge. In these studies, we used an in vitro approach to determine mechanisms involved at the molecular level. First, we validated the system by determining whether expression of ⌬CnA in cultured rat astrocytes also ameliorated the subsequent response to inflammatory challenge. Indeed, as seen in vivo in AIC mice, astrocytes expressing ⌬CnA before inflammatory challenge show reduced increases of the inflammatory effectors Cox2 and iNOS2 16 h after LPS (Fig. 5A ) or 3 h after TNF-␣ (data not shown). Other proinflammatory signals were also inhibited (Table 1) . With this system, we next observed that, in ⌬CnA-transfected astrocytes, but not in mock-transfected ones, LPS-or TNF-␣-induced activation of NFB and NFAT was inhibited even below basal levels ( p Ͻ 0.001 vs CMV astrocytes) (Fig. 5B ). This inhibitory effect of ⌬CnA was not seen in neurons (supplemental Fig. 3A , available at www.jneurosci.org as supplemental material). Confirming these results in rat astrocytes, we found that NFB and NFAT activity after inflammatory challenge was again inhibited below basal levels in astrocytes from AIC mice expressing ⌬CnA, i.e., cultured in the absence of Dox (Fig. 5C ).
Mechanisms whereby calcineurin may block the activation of NFB and NFAT by proinflammatory stimuli were then analyzed. As seen previously after IGF-Iinduced activation of calcineurin (Pons and Torres-Aleman, 2000) , expression of ⌬CnA in astrocytes blocked phosphorylation of IB␣ by TNF-␣ (Fig. 5D) . Furthermore, expression of ⌬CnA blocked the increase in the levels of NFBp65 and NFAT4 (an isoform found in astrocytes) (Jones et al., 2003) elicited by 16 h of exposure to LPS or 3 h after TNF-␣ (data not shown) in mock-transfected astrocytes (Fig. 5E ) (supplemental Fig. 3B ) ( p Ͻ 0.001 vs CMV-transfected astrocytes; n ϭ 6). We next explored mechanism whereby expression of ⌬CnA results in reduced levels of NFBp65 and NFAT4 after inflammatory challenge. First, we inhibited the proteasome pathway with MG-132 and found that the effect of ⌬CnA was blocked ( Fig. 5F ) (supplemental Fig. 3C , available at www.jneurosci.org as supplemental material) ( p Ͻ 0.001 vs ⌬CnA astrocytes; n ϭ 6). This suggested that the proteasome pathway is involved in the reduction of the levels of NFBp65 and NFAT4 produced by ⌬CnA. In agreement with this possibility, we observed that ⌬CnA-expressing astrocytes had increased NFBp65 and NFAT4 complexed with ubiquitin, a protein tag to the proteasome pathway ( p Ͻ 0.001 vs CMV-transfected astrocytes; n ϭ 6) ( Fig. 5G) (supplemental Fig. 3D , available at www.
jneurosci.org as supplemental material). At the same time, the inhibitory action of ⌬CnA was accompanied by increased association of NFAT4 with GATA3 (an isoform of brain tissue) (Pandolfi et al., 1995) and of NFBp65 with PPAR␥ (Fig. 5H ) Figure 5 . Calcineurin inhibits the NFB/NFAT proinflammatory pathway in astrocytes. A, LPS failed to stimulate Cox2 and iNOS2 in astrocytes expressing ⌬CnA. A representative blot is shown (n ϭ 6). B, LPS-or TNF-␣-induced activation of NFB and NFAT was abrogated in ⌬CnA-transduced astrocytes. The activity of these transcription factors was inhibited after exposure to LPS/TNF-␣ in ⌬CnA-expressing astrocytes. Note that expression of ⌬CnA in unstimulated astrocytes reduced the activity of NFB and NFAT. CMV, Astrocytes transfected with the empty vector; ⌬CnA, astrocytes transfected with constitutively active calcineurin; CMVϩNFB or NFAT, mock-transfected astrocytes expressing the gene-reporter system for either transcription factor; ⌬CnAϩNFB or NFAT, ⌬CnA-transfected astrocytes expressing the gene-reporter system. ***p Ͻ 0.001 versus respective controls (n ϭ 6). C, In astrocytes from AIC mice, activation of NFB and NFAT after LPS (left) or TNF-␣ (right) was regulated by Dox, confirming that expression of ⌬CnA suppresses it. **p Ͻ 0.01 and ***p Ͻ 0.001 versus respective controls. D, Expression of ⌬CnA blocks phosphorylation of IB␣ induced by TNF-␣ (20 ng/ml, 15 min of exposure, representative blot). Mock-transfected cultures received the pCMV vector. E, Exposure of mock-transfected astrocytes to LPS elicited an increase in NFBp65 (left) and NFAT4 (right) protein levels 16 h later. This increase was significantly attenuated in astrocytes expressing ⌬CnA. F, The inhibitory effect of ⌬CnA on NFBp65/NFAT4 levels was blocked by the proteasome inhibitory drug MG-132 (MG). G, ⌬CnA-expressing astrocytes have significantly increased NFBp65 and NFAT4 complexed with ubiquitin. Immunoprecipitation with anti-NFBp65 or anti-NFAT4 followed by blotting with anti-ubiquitin (top blots). H, Astrocytes transduced with ⌬CnA had increased levels of NFBp65/PPAR␥ and NFAT/GATA3 compared with control astrocytes. Immunoprecipitation with anti-PPAR␥ and anti-GATA3 followed by blotting with either anti-NFBp65 or anti-NFAT4 (top blots). The opposite immunoprecipitations gave similar results (data not shown). In all cases, levels of ␤-actin or the respective immunoprecipitated protein were determined for protein load (bottom blots). Representative blots (of 6 for each experiment) are shown. All changes were significantly different (see Results).
(supplemental Fig. 3E , available at www.jneurosci.org as supplemental material) ( p Ͻ 0.001 vs CMV astrocytes; n ϭ 6). These two transcription factors modulate the activity of NFB and NFAT, respectively (Avni et al., 2002; Bailey and Ghosh, 2005) . Similar changes were seen in astrocytes obtained from AIC mice and cultured in the presence or absence of Dox (data not shown).
Astrocyte calcineurin is recruited by both proinflammatory and anti-inflammatory signals
Although our results indicated that active calcineurin counteracts a subsequent inflammatory stimulus, this phosphatase is known to participate in inflammatory responses (Staruch et al., 1998) . Indeed, as seen in other cell types, in quiescent wt astrocytes, calcineurin is activated by LPS and TNF-␣ (Fig. 6 A) . Moreover, when endogenous calcineurin is depleted in wt astrocytes by transfection of an siRNA against calcineurin, the production of inflammatory mediators such as iNOS2 or Cox2 in response to LPS is abrogated (Fig. 6 B) . LPS and TNF-␣ also stimulated the activity of the proinflammatory transcription factors NFB and NFAT and in a calcineurindependent manner, as evidenced by its blockade with CsA (Fig. 6C) .
However, an anti-inflammatory factor such as IGF-I, which inhibits TNF-␣-stimulated NFB in astrocytes (Pons and Torres-Aleman, 2000) , also enhanced calcineurin activity in wt astrocytes (Fig. 6 A) . At the same time, IGF-I was able to inhibit the increase in NFB and NFAT activity after inflammatory stimuli (Fig. 6 D) . That activation of calcineurin in astrocytes is essential for the neuroprotective actions of IGF-I against inflammation was evidenced by the fact that IGF-I rescued neurons of TNF-␣-induced death (Fig. 6 E) or block neuronal production of ROS after TNF-␣ (Fig. 6 F) only when astrocytes were present. A similar protective effect of IGF-I was seen after LPS (data not shown). Furthermore, calcineurin was essential for IGF-I neuroprotection because cyclosporine A inhibited its actions (Fig. 6 E) . Because IGF-I is found in reactive astrocytes in brain lesions in which inflammation occurs (supplemental Fig. 3F , available at www.jneurosci.org as supplemental material), it may activate astrocyte calcineurin during brain injury.
Discussion
Glial cells are a rich source of trophic signals for neurons, and its potential use as therapeutic targets in neurodegenerative diseases has already been outlined (Ranaivo et al., 2006) . However, a better knowledge of the pathways involved in glia-to-neuron protective communication is needed before we can properly address this goal. Our present observations indicate that the phosphatase calcineurin in astrocytes modulates neuronal damage associated with inflammation, a common condition in the neurodegenerative process (Minghetti, 2005) . Intriguingly, in brain diseases in which inflammation is involved such as Alzheimer's disease (Mrak and Griffin, 2005) or amyotrophic lateral sclerosis (Weydt et al., 2002) , calcineurin activity has been reported to be abnormally low (Ladner et al., 1996; Ferri et al., 2001) , whereas in situ generation of constitutively active calcineurin is neuroprotective in brain ischemia (Shioda et al., 2006) .
Although the role of calcineurin in inflammation has long Figure 6 . Astrocytic calcineurin participates in proinflammatory and in anti-inflammatory signaling. A, In wt astrocytes, calcineurin activity was incremented by proinflammatory stimuli such as LPS/TNF-␣ and by neuroprotective signals such as IGF-I. **p Ͻ 0.01 and ***p Ͻ 0.001 versus control. B, In astrocytes transfected with a calcineurin-specific siRNA (CnA3), the production of inflammatory mediators such as iNOS2 or Cox2 in response to inflammatory challenge (LPS) was abrogated in parallel to inhibited calcineurin levels. Controls, Astrocytes transfected with non-sense siRNA; GAPDH, astrocytes transfected with GAPDH siRNA. Note that, although levels of this protein are depleted, the response to LPS/TNF-␣ remains intact. Representative blots are shown (n ϭ 6). Other CnA siRNAs tested gave similar results (data not shown). C, LPS/TNF-␣-stimulated activity of NFB and NFAT was abrogated in the presence of CsA. NFB and NFAT denote transfection of astrocytes with NFB and NFAT reporters, respectively. **p Ͻ 0.01 and ***p Ͻ 0.001 versus untreated controls (shown in left white bars). D, IGF-I inhibited the increase induced by LPS or TNF-␣ in the activity of NFB and NFAT. ***p Ͻ 0.001 versus unstimulated controls (n ϭ 6). ***p Ͻ 0.001 versus unstimulated controls. E, IGF-I protected neurons against TNF-␣-induced death only in the presence of astrocytes. This effect was blocked by CsA. Neurons were exposed to TNF-␣ overnight. F, Production of ROS after LPS challenge was blocked by IGF-I only in the presence of astrocytes. *p Ͻ 0.05 and ***p Ͻ 0.001 versus respective controls (n ϭ 6).
Although the routes involved in stimulation of NFAT and NFB are well described, the pathways involved in their inactivation are less known. The present results suggest that calcineurin inhibits NFB by dephosphorylation of nuclear factor B inhibitor (IB) and interactions with PPAR␥, and NFAT through interactions with GATA. Both transcription factors have been shown previously to interact with NFAT and NFB, respectively (Chinetti et al., 1998; Wada et al., 2002) . Intriguingly, recent evidence indicates that not only calcineurin (see above) but also PPAR␥ activity is diminished in Alzheimer's disease patients (Sastre et al., 2006) . Calcineurin may also direct NFAT and NFB to the proteasome pathway because lower levels of both transcription factors together with increased association to ubiquitin was observed in the presence of ⌬CnA. Our results also confirm the stimulatory role of calcineurin on neuroprotective signals such as SOD and IGF-I (McCall et al., 2003; Norris et al., 2005) , providing a conceptual framework to understand the contribution of astroglia to neuronal death in diseases such as amyotrophic lateral sclerosis (Clement et al., 2003) , in which these neuroprotective signals are involved (Wilczak et al., 2003; Turner et al., 2005) .
Altogether, it seems that calcineurin plays a dual role in activating proinflammatory cascades in response to proinflammatory signals such as TNF-␣ or canceling them and at the same time promoting neuroprotection in response to trophic signals such as IGF-I. At any rate, the pathways underlying this dual action of calcineurin, which probably involves interactions with scaffolding and modulatory proteins (Klauck et al., 1996; Fuentes et al., 2000; Abbasi et al., 2006) , and release of various neuromodulators warrant additional studies.
In summary, astrocyte calcineurin may constitute a key element in the process whereby an acute inflammatory response progresses toward a neuroprotective effect and is resolved or develops into a sustained insult.
